{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T05:15:17Z","timestamp":1734758117880,"version":"3.32.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"DOI":"10.7759\/cureus.76057","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T09:52:55Z","timestamp":1734688375000},"source":"Crossref","is-referenced-by-count":0,"title":["The Efficacy and Safety of Radio Electric Asymmetric Conveyer (REAC) External Radio Electric Reprogramming for Atrial Fibrillation (EX-RER AF) Treatment: Results From a Post-market Clinical Follow-Up"],"prefix":"10.7759","author":[{"given":"Salvatore","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vania","family":"Fontani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Atrial fibrillation: the most common arrhythmia","volume":"27","author":"Wyndham CR","year":"2000","unstructured":"Wyndham CR. Atrial fibrillation: the most common arrhythmia. Tex Heart Inst J. 2000, 27:257-67.","journal-title":"Tex Heart Inst J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall G","year":"2006","unstructured":"Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006, 119:448.e1-19. 10.1016\/j.amjmed.2005.10.057","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvdhj.2023.06.004","article-title":"Episodes of atrial fibrillation and symptoms: a temporal analysis","volume":"4","author":"Ghanbari H","year":"2023","unstructured":"Ghanbari H, Whibley D, Lehmann HI, Li Z, Kratz A, Clauw DJ, Nallamothu BK. Episodes of atrial fibrillation and symptoms: a temporal analysis. Cardiovasc Digit Health J. 2023, 4:143-8. 10.1016\/j.cvdhj.2023.06.004","journal-title":"Cardiovasc Digit Health J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2024.08.013","article-title":"Associations between atrial fibrillation symptom clusters and major adverse cardiovascular events following catheter ablation","volume":"5","author":"Scharp D","year":"2024","unstructured":"Scharp D, Zhao Y, Van Bulck L, Volodarskiy A, Slotwiner D, Reading Turchioe M. Associations between atrial fibrillation symptom clusters and major adverse cardiovascular events following catheter ablation. Heart Rhythm O2. 2024, 5:741-3. 10.1016\/j.hroo.2024.08.013","journal-title":"Heart Rhythm O2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1110424","article-title":"Association between cardiovascular risk factors and atrial fibrillation","volume":"10","author":"Wu G","year":"2023","unstructured":"Wu G, Wu J, Lu Q, Cheng Y, Mei W. Association between cardiovascular risk factors and atrial fibrillation. Front Cardiovasc Med. 2023, 10:1110424. 10.3389\/fcvm.2023.1110424","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-058568","article-title":"Paroxysmal atrial fibrillation","volume":"375","author":"Gahungu N","year":"2021","unstructured":"Gahungu N, Trueick R, Coopes M, Gabbay E. Paroxysmal atrial fibrillation. BMJ. 2021, 375:e058568. 10.1136\/bmj-2021-058568","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39143.720602.BE","article-title":"Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat","volume":"334","author":"Camm AJ","year":"2007","unstructured":"Camm AJ, Savelieva I. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat. BMJ. 2007, 334:637. 10.1136\/bmj.39143.720602.BE","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-04418-9.50089-8","article-title":"Chapter 85 - the diagnosis and management of cardiac dysrhythmias","author":"Sperry JL","year":"2008","unstructured":"Sperry JL, Minei JP. Chapter 85 - the diagnosis and management of cardiac dysrhythmias. Current therapy of trauma and surgical critical care. Asensio JA, Trunkey DD (ed): Mosby, Maryland Heights, MO; 2008. 602-9. 10.1016\/B978-0-323-04418-9.50089-8"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000738","article-title":"New perspectives in the management of paroxysmal atrial fibrillation: dual antiarrhythmic medications","author":"Al-Jammali S","year":"2024","unstructured":"Al-Jammali S, Al-Zakhari R, Mahtani AU, Isber N. New perspectives in the management of paroxysmal atrial fibrillation: dual antiarrhythmic medications. Cardiol Rev. 2024, 10.1097\/CRD.0000000000000738","journal-title":"Cardiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.638445","article-title":"Current drug treatment strategies for atrial fibrillation and TASK-1 inhibition as an emerging novel therapy option","volume":"12","author":"Kraft M","year":"2021","unstructured":"Kraft M, B\u00fcscher A, Wiedmann F, et al.. Current drug treatment strategies for atrial fibrillation and TASK-1 inhibition as an emerging novel therapy option. Front Pharmacol. 2021, 12:638445. 10.3389\/fphar.2021.638445","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2023658","article-title":"Atrial fibrillation","volume":"384","author":"Michaud GF","year":"2021","unstructured":"Michaud GF, Stevenson WG. Atrial fibrillation. N Engl J Med. 2021, 384:353-61. 10.1056\/NEJMcp2023658","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206106","article-title":"Comparison of SF-36 and RAND-36 in cardiovascular diseases: a reliability study","volume":"13","author":"Garc\u00eda-S\u00e1nchez E","year":"2024","unstructured":"Garc\u00eda-S\u00e1nchez E, Santamar\u00eda-Pel\u00e1ez M, Benito Figuerola E, et al.. Comparison of SF-36 and RAND-36 in cardiovascular diseases: a reliability study. J Clin Med. 2024, 13:6106. 10.3390\/jcm13206106","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae070","article-title":"Longer and better lives for patients with atrial fibrillation: the 9th AFNET\/EHRA consensus conference","volume":"26","author":"Linz D","year":"2024","unstructured":"Linz D, Andrade JG, Arbelo E, et al.. Longer and better lives for patients with atrial fibrillation: the 9th AFNET\/EHRA consensus conference. Europace. 2024, 26:euae070. 10.1093\/europace\/euae070","journal-title":"Europace"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Kang H","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021, 18:17. 10.3352\/jeehp.2021.18.17","journal-title":"J Educ Eval Health Prof"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-2-26","article-title":"Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36","volume":"2","author":"Walters SJ","year":"2004","unstructured":"Walters SJ. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36. Health Qual Life Outcomes. 2004, 2:26. 10.1186\/1477-7525-2-26","journal-title":"Health Qual Life Outcomes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1081\/copd-200053374","article-title":"Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions","volume":"2","author":"Sloan JA","year":"2005","unstructured":"Sloan JA. Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions. COPD. 2005, 2:57-62. 10.1081\/copd-200053374","journal-title":"COPD"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.09.044","article-title":"Long-term health-related quality of life and rhythm outcomes of catheter ablation versus antiarrhythmic drugs in patients with atrial fibrillation","author":"Svedung Wettervik V","year":"2024","unstructured":"Svedung Wettervik V, Schwieler J, Bergfeldt L, et al.. Long-term health-related quality of life and rhythm outcomes of catheter ablation versus antiarrhythmic drugs in patients with atrial fibrillation. Heart Rhythm. 2024, 10.1016\/j.hrthm.2024.09.044","journal-title":"Heart Rhythm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.36660\/ijcs.20230093","article-title":"Evolution of patients with atrial fibrillation according to the EHRA categorization","volume":"37","author":"Silva RM","year":"2024","unstructured":"Silva RM, Diniz LT, Gomes LS, Borges LE. Evolution of patients with atrial fibrillation according to the EHRA categorization. Int J Cardiovasc Sci. 2024, 37:e20230093. 10.36660\/ijcs.20230093","journal-title":"Int J Cardiovasc Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00886-x","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian P","year":"2000","unstructured":"Dorian P, Jung W, Newman D, et al.. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000, 36:1303-9. 10.1016\/s0735-1097(00)00886-x","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13061019","article-title":"Impact of REAC regenerative endogenous bioelectrical cell reprogramming on MCF7 breast cancer cells","volume":"13","author":"Fontani V","year":"2023","unstructured":"Fontani V, Cruciani S, Santaniello S, Rinaldi S, Maioli M. Impact of REAC regenerative endogenous bioelectrical cell reprogramming on MCF7 breast cancer cells. J Pers Med. 2023, 13:1019. 10.3390\/jpm13061019","journal-title":"J Pers Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060937","article-title":"Improving functional capacity and quality of life in Parkinson\u2019s disease patients through REAC neuromodulation treatments for mood and behavioral disorders","volume":"13","author":"Rinaldi C","year":"2023","unstructured":"Rinaldi C, Landre CB, Volpe MI, et al.. Improving functional capacity and quality of life in Parkinson\u2019s disease patients through REAC neuromodulation treatments for mood and behavioral disorders. J Pers Med. 2023, 13:937. 10.3390\/jpm13060937","journal-title":"J Pers Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68200-5","article-title":"Neurobiological modulation with REAC technology: enhancing pain, depression, anxiety, stress, and quality of life in post-polio syndrome subjects","volume":"14","author":"Andr\u00e9 Nogueira JA","year":"2024","unstructured":"Andr\u00e9 Nogueira JA, Souza Bulle Oliveira A, Pereira Motta M, et al.. Neurobiological modulation with REAC technology: enhancing pain, depression, anxiety, stress, and quality of life in post-polio syndrome subjects. Sci Rep. 2024, 14:17222. 10.1038\/s41598-024-68200-5","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72819","article-title":"Non-invasive gamma brain wave optimization (BWO-G) for cognitive and emotional recovery in an adolescent: a case study on radio electric asymmetric conveyer (REAC) neuro psycho physical optimization (NPPO) BWO-G treatment","volume":"16","author":"Modesto' V","year":"2024","unstructured":"Modesto' V, Rinaldi A, Fontani V, Rinaldi S. Non-invasive gamma brain wave optimization (BWO-G) for cognitive and emotional recovery in an adolescent: a case study on radio electric asymmetric conveyer (REAC) neuro psycho physical optimization (NPPO) BWO-G treatment. Cureus. 2024, 16:e72819. 10.7759\/cureus.72819","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14101018","article-title":"Efficacy of REAC neurobiological optimization treatments in post-polio syndrome: a manual muscle testing evaluation","volume":"14","author":"Pereira Motta M","year":"2024","unstructured":"Pereira Motta M, Oliveira AS, Andr\u00e9 Nogueira JA, et al.. Efficacy of REAC neurobiological optimization treatments in post-polio syndrome: a manual muscle testing evaluation. J Pers Med. 2024, 14:1018. 10.3390\/jpm14101018","journal-title":"J Pers Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.15570\/actaapa.2020.24","article-title":"REAC-induced endogenous bioelectric currents in the treatment of venous ulcers: a three-arm randomized controlled prospective study","volume":"29","author":"Elio C","year":"2020","unstructured":"Elio C, Fontani V, Rinaldi S, Gasbarro V. REAC-induced endogenous bioelectric currents in the treatment of venous ulcers: a three-arm randomized controlled prospective study. Acta Dermatovenerol Alp Pannonica Adriat. 2020, 29:109-13. 10.15570\/actaapa.2020.24","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325223-the-efficacy-and-safety-of-radio-electric-asymmetric-conveyer-reac-external-radio-electric-reprogramming-for-atrial-fibrillation-ex-rer-af-treatment-results-from-a-post-market-clinical-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T09:52:57Z","timestamp":1734688377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325223-the-efficacy-and-safety-of-radio-electric-asymmetric-conveyer-reac-external-radio-electric-reprogramming-for-atrial-fibrillation-ex-rer-af-treatment-results-from-a-post-market-clinical-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.76057","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}